Expand Treatment Access Without Compromising Safety or Outcomes

Unlike older ablation technologies that exclude patients based on uterine size, prior surgeries, or anesthesia risks, Minitouch is designed to treat a wider variety of patients safely and effectively. With no cavity size restrictions, no need for general anesthesia, and a gentler approach, Minitouch makes endometrial ablation accessible to more women while maintaining exceptional clinical outcomes.

Minitouch Expands Treatment Options

Treat a Wider Variety of Patients

Many second-generation ablation devices have strict patient selection criteria, excluding those with:

Minitouch was built with a safer, more effective method, ensuring these patients can receive treatment without increased risks.

Safety Data Across Patient Groups

Dysmenorrhea (Severe Period Pain)

Larger or irregular uterine cavities

Obesity or higher BMI

Prior C-sections or uterine surgeries

Medical contraindications for general anesthesia

Why Minitouch Can Treat More Patients

By eliminating the limitations of older ablation methods, Minitouch allows physicians to treat more patients with a safer, simpler in-office procedure.

Compare Minitouch

No General Anesthesia Required

Safe for women with anesthesia sensitivities

No Uterine Distension or Pressure Required

Allows treatment for larger cavities

No Cervical Dilation in 92% of Cases

Reduces discomfort for patients with prior surgeries

Shaped Electromagnetic Field (EM)

Provides deep, even treatment without direct tissue contact

Minitouch allows physicians to offer endometrial

ablation to a broader patient population—including those with larger uterine cavities, prior C-sections, dysmenorrhea, and anesthesia risks—without sacrificing safety or success rates.

Request a Demo for Your Practice